The role of empiric atypical antibiotic coverage in non-severe community-acquired pneumonia
A β–lactam plus a macrolide or a respiratory fluoroquinolone alone is recommended as standard empiric antibacterial therapy for non-severe adults hospitalized with community-acquired pneumonia (CAP) per Infectious Diseases Society of America guidelines. However, the evidence in support of adding emp...
Saved in:
| Main Authors: | Whitney Hartlage, Hannah Imlay, Emily S. Spivak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2024-01-01
|
| Series: | Antimicrobial Stewardship & Healthcare Epidemiology |
| Online Access: | https://www.cambridge.org/core/product/identifier/S2732494X24004534/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibiotic Therapy of Severe Community-Acquired Pneumonia
by: O. V. Molchanova, et al.
Published: (2020-05-01) -
Comparison of initial empirical antibiotic regimens in severe community-acquired pneumonia: a network meta-analysis
by: Min Wang, et al.
Published: (2025-05-01) -
The Practice of Antibiotic Therapy of Severe Community-Acquired Pneumonia in Adults in Russian Multidisciplinary Hospitals
by: S. A. Rachina, et al.
Published: (2022-04-01) -
Evaluation of the Efficacy and Safety of Initial Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Middle-Aged People
by: T. V. Alexandrova, et al.
Published: (2022-07-01) -
Weighing options: empiric antibiotic use and stewardship opportunities in critically ill patients with community-acquired pneumonia
by: Nalea Trujillo, et al.
Published: (2025-01-01)